SMAD4 and prostate carcinoma: In addition, the TGF-β/Smad4 pathway has also been determined as the downstream pathway of specific miRNAs in diverse cancers, such as miR-539 in prostate cancer [31], miR-183 in ovarian cancer [32], and miR-34a in colorectal cancer [33].